Last Updated on October 11, 2024 by The Health Master
Global Pharma Healthcare is voluntarily recalling all lots within expiry of their Artificial Tears Lubricant Eye Drops, distributed by /EzriCare, LLC- and Delsam Pharma, to the consumer level, due to possible contamination.
The Centers for Disease Control and Prevention (CDC) alerted FDA to an investigation of a multi-state cluster of Verona Integron-mediated Metallo-β-lactamase (VIM)- and Guiana-Extended Spectrum-β-Lactamase (GES)- producing carbapenem-resistant Pseudomonas aeruginosa (VIM-GES-CRPA) infections possibly associated with the use of the artificial tears manufactured by Global Pharma Healthcare.
To date, there are 55 reports of adverse events including eye infections, permanent loss of vision, and a death with a bloodstream infection.
Risk Statement: Use of contaminated artificial tears can result in the risk of eye infections that could result in blindness.
Artificial Tears (carboxymethylcellulose sodium) Lubricant Eye Drops, 10 mg in 1 mL, ½ fl oz (15 ml) bottle are used as a protectant against further irritation or to relieve dryness of the eye for the temporary relief of discomfort due to minor irritations of the eye, or to exposure to wind or sun.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Drug recall: 3,665 Bottles of this antifungal drug recalled due to this reason
Drug recall: Over 34,000 bottles of Diltiazem HCL capsules recalled due to this reason
Drug recall: 5,720 tubes of Clobetasol Propionate Cream recalled due to this reason
Drug recall: These Lots of Levothyroxine sodium Oral Solution recalled
Drug recall: Bharat Biotech voluntarily recalls ChiroRaba vaccine due to this reason
Drug recall: Rifampin Capsules recalled due to this reason
FDA issues show cause notices to 17 Pharma manufacturers: Maharashtra
Pharma API Leaders discusses regulatory compliance
USFDA gives approval for Rocuronium Bromide Injection
22 Pharma Firms come under GST radar
Spurious drugs worth Rs 7.3 cr seized in UP: Odisha connection
Govt soon to announce R&D policy for Pharma Sector
Spurious drugs worth Rs 2 lakh seized, distributor arrested
NPPA revised Ceiling price of 80 scheduled formulations: February 2023
Duties and responsibilities of QA person in Pharma Industry
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
